Epilepsy, osteoporosis and fracture risk - a meta-analysis
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
This meta-analysis assesses the effects of epilepsy on fracture risk and changes in bone mineral density (BMD) in patients with epilepsy. A search of PubMed was conducted using the key words epilepsy, fracture, and bone mineral. A weighted estimate of relative risk of fractures and changes in BMD (Z-score) was calculated. From the changes in BMD, expected increase in relative fracture risk was calculated. A total of 11 studies on fracture risk and 12 studies on BMD were retrieved. The relative risk of any fracture was increased (2.2, 95% CI: 1.9-2.5, five studies), as was the risk of hip (5.3, 3.2-8.8, six studies), forearm (1.7, 1.2-2.3, six studies), and spine fractures (6.2, 2.5-15.5, three studies). A large proportion of fractures (35%) seemed related to seizures. Spine (mean +/- SEM: -0.38 +/- 0.06) and hip (-0.56 +/- 0.06) BMD Z-scores were significantly decreased, hip more than spine (2P < 0.05). The expected increases in relative risk of any fracture from BMD Z-scores were 1.2-1.3, and significantly lower than observed (2P < 0.05). The deficit in BMD in patients with epilepsy is too small to explain the observed increase in fracture risk. The remainder of the increase in fracture risk may be linked to seizures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602 · cited 1×
“The latter may be achieved through the use of (i) calcium plus vitamin D (50, 51) – this is of particular importance in institutionalized, and elderly subjects (25), or (ii) antiosteoporotic drugs [bisphosphonates (52–54), SERMs (55), strontium (56, 57), and in selected cases parathyroid hormone (58)].”
BackgroundBlack, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846 · cited 1×
“This would tend to overestimate the risk estimate, as many spine fractures are asymptomatic (36).”
BackgroundMarshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Vitamin D3and Calcium to Prevent Hip Fractures in Elderly Women
Chapuy, M. C., Arlot, M. E., Duboeuf, F., Brun, J., Crouzet, B., Arnaud, S., Delmas, P. D., & Meunier, P. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272305 · Cited by 2,950
ASSESSMENT OF FRACTURE RISK AND ITS APPLICATION TO SCREENING FOR POSTMENOPAUSAL OSTEOPOROSIS
Alexeeva, L. P., Burkhardt, P., Christiansen, C., Cooper, C. C., Delmas, P. D., Johnell, O., Johnston, C. C., Kanis, J. A., Lips, P. T. A. M., Melton, L. J., et al. (1994) · Cited by 2,655
Use of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Central Nervous System–Active Medications and Risk for Falls in Older Women
Ensrud, K. E., Blackwell, T. L., Mangione, C. M., Bowman, P. J., Whooley, M. A., Bauer, D. C., Schwartz, A. V., Hanlon, J. T., Nevitt, M. C., & For The Study of Osteoporotic Fractures Research Group (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50453.x · Cited by 620 · cited 1×
“A similar effect with unsteadiness and an increased risk of falling may also be seen with the AEDs per se (35).”
BackgroundEffect of external hip protectors on hip fractures
Lauritzen, J. B., Petersen, M. M., & Lund, B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92480-h · Cited by 620 · cited 1×
“through the use of hip protectors in institutionalized subjects to prevent fractures during a fall (49)], (iii) prevent loss of bone mineral.”
BackgroundThe Epidemiology of the Comorbidity of Epilepsy in the General Population
Gaitatzis, A., Carroll, K., Majeed, A., & Sander, J. W. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.17504.x · Cited by 603 · cited 2×
“Any 1.95 (1.87–2.04) 43 52 Case–control All fracture cases (n ¼ 124,655) during 1 year, 373,962 age- and gender-matched controls; 3178 cases and 4947 controls had an epilepsy diagnosis 8125 Denmark (27) 2.0 (1.6–2.5) 45 50 Cohort Free-living subjects (n ¼ 345), controls (n ¼ 654) randomly drawn from the background pop…”
BackgroundInfluentialII. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women
Cranney, A., Wells, G., Willan, A., Griffith, L., Zytaruk, N., Robinson, V., Black, D., Adachi, J., Shea, B., Tugwell, P., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-2002 · Cited by 445
Primer on the metabolic bone diseases and disorders of mineral metabolism
Fogelman, I., & Cook, G. (2003) · Cited by 404
VII. Meta-Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis
Shea, B., Wells, G., Cranney, A., Zytaruk, N., Robinson, V., Griffith, L., Ortiz, Z., Peterson, J., Adachi, J., Tugwell, P., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-7002 · Cited by 399 · cited 1×
“The latter may be achieved through the use of (i) calcium plus vitamin D (50, 51) – this is of particular importance in institutionalized, and elderly subjects (25), or (ii) antiosteoporotic drugs [bisphosphonates (52–54), SERMs (55), strontium (56, 57), and in selected cases parathyroid hormone (58)].”
BackgroundOfficial Positions of the International Society for Clinical Densitometry
Leib, E. S., Lewiecki, E. M., Binkley, N., & Hamdy, R. C. (2004) · Journal of Clinical Densitometry · doi:10.1385/jcd:7:1:1 · Cited by 389
Effect of antiepileptic drugs on bone density in ambulatory patients
Farhat, G., Yamout, B., Mikati, M. A., Demirjian, S., Sawaya, R., & El-Hajj Fuleihan, G. (2002) · Neurology · doi:10.1212/wnl.58.9.1348 · Cited by 358
Meunier, P. J. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2060 · Cited by 337
Ramnemark, A., Nyberg, L., Borssén, B., Olsson, T., & Gustafson, Y. (1998) · Osteoporosis International · doi:10.1007/s001980050053 · Cited by 317 · cited 1×
“Patients with cerebral palsy and stroke may have a decreased BMD only in the limbs affected by paresis (32, 33), and this may increase the risk of fractures.”
BackgroundPapadimitropoulos, E., Wells, G., Shea, B., Gillespie, W., Weaver, B., Zytaruk, N., Cranney, A., Adachi, J., Tugwell, P., Josse, R., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-8002 · Cited by 302
Effect of carbamazepine and valproate on bone mineral density
Sheth, R. D., Wesolowski, C. A., Jacob, J. C., Penney, S., Hobbs, G. R., Riggs, J. E., & Bodensteiner, J. B. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70304-7 · Cited by 293 · cited 1×
“(42) who reported that valproic acid reduced spinal BMD, while carbamazepine did not.”
BackgroundIII. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis
Cranney, A., Tugwell, P., Adachi, J., Weaver, B., Zytaruk, N., Papaioannou, A., Robinson, V., Shea, B., Wells, G., & Guyatt, G. (2002) · Endocrine Reviews · doi:10.1210/er.2001-3002 · Cited by 281
Fracture Risk Associated with Use of Antiepileptic Drugs
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.18804.x · Cited by 241 · cited 8×
“Patients on phenytoin have a decrease in BMD (39), that converted to an increase in expected fracture risk close to that observed in previous studies among users of phenytoin (3, 27).”
BackgroundResultInfluentialSelf-citationComputer-Assisted Analysis of Mixtures and Applications: Meta-Analysis, Disease Mapping, and Others
Böhning, D. (1999) · Medical Entomology and Zoology · Cited by 220
Guo, C., Ronen, G. M., & Atkinson, S. A. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.416800.x · Cited by 203 · cited 1×
“(43) reported that both valproate and lamotrigine were associated with a decreased total body BMD, a short stature, and a reduced bone formation.”
BackgroundFracture risk is increased in epilepsy
Vestergaard, P., Tigaran, S., Rejnmark, L., Tigaran, C., Dam, M., & Mosekilde, L. (1999) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00675.x · Cited by 197 · cited 10×
“The latter fractures may thus also be seen in patients who do not experience convulsions (3).”
BackgroundResultInfluentialSelf-citationDr. Välimäki, M. J., Tiihonen, M., Laitinen, K., Tähtelä, R., Kärkkäinen, M., Lamberg-Allardt, C., Mäkelä, P., & Tunninen, R. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090507 · Cited by 177
IV. Meta-Analysis of Raloxifene for the Prevention and Treatment of Postmenopausal Osteoporosis
Cranney, A., Tugwell, P., Zytaruk, N., Robinson, V., Weaver, B., Adachi, J., Wells, G., Shea, B., Guyatt, G., The Osteoporosis Methodology Group, et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-4002 · Cited by 172
Jørgensen, L., Jacobsen, B. K., Wilsgaard, T., & Magnus, J. H. (2000) · Osteoporosis International · doi:10.1007/s001980070103 · Cited by 171 · cited 1×
“Patients with cerebral palsy and stroke may have a decreased BMD only in the limbs affected by paresis (32, 33), and this may increase the risk of fractures.”
BackgroundBone density and antiepileptic drugs: a case-controlled study
Stephen, L. J., McLellan, A. R., Harrison, J. H., Shapiro, D., Dominiczak, M. H., Sills, G. J., & Brodie, M. J. (1999) · Seizure · doi:10.1053/seiz.1999.0301 · Cited by 159 · cited 1×
“(40) reported lower femoral neck BMD in patients on liver-inducing AEDs (carbamazepine, phenobarbital, phenytoin) than in those on non-inducing drugs (lamotrigine, topiramate, valproate, vigabatrin, gabapentin), while no difference could be demonstrated in the spine.”
BackgroundA Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis
Cranney, A., Guyatt, G. H., Krolicki, N., Welch, V. A., Griffith, L. E., Adachi, J. D., Shea, B., Tugwell, P., & Wells, G. A. (2001) · Osteoporosis International · doi:10.1007/s001980170147 · Cited by 145
Case-Control Study of the Pathogenesis and Sequelae of Symptomatic Vertebral Fractures in Men
Scane, A. C., Francis, R. M., Sutcliffe, A., Francis, M. J. D., Rawlings, D. J., & Chapple, C.-L. (1999) · Osteoporosis International · doi:10.1007/s001980050120 · Cited by 124 · cited 2×
“Any 1.95 (1.87–2.04) 43 52 Case–control All fracture cases (n ¼ 124,655) during 1 year, 373,962 age- and gender-matched controls; 3178 cases and 4947 controls had an epilepsy diagnosis 8125 Denmark (27) 2.0 (1.6–2.5) 45 50 Cohort Free-living subjects (n ¼ 345), controls (n ¼ 654) randomly drawn from the background pop…”
BackgroundInfluentialEvaluation of bone mineral density in children receiving antiepileptic drugs
Akın, R. I., Okutan, V., Sarıcı, Ü., Altunbaş, A., & Gökçay, E. (1998) · Pediatric Neurology · doi:10.1016/s0887-8994(98)00039-3 · Cited by 110 · cited 2×
“In the two studies in children on valproate vs carbamazepine, patients on valproate had BMD close to or a little lower than expected, while patients on carbamazepine had BMD a little, but not significantly higher than expected (37, 38).”
BackgroundBone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs
Pack, A. M., Olarte, L. S., Morrell, M. J., Flaster, E. R., Resor, S. R., & Shane, E. J. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00036-2 · Cited by 106
Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children
Chung, S., & Ahn, C.-I. (1994) · Brain and Development · doi:10.1016/0387-7604(94)90125-2 · Cited by 94 · cited 2×
“Patients on phenytoin have a decrease in BMD (39), that converted to an increase in expected fracture risk close to that observed in previous studies among users of phenytoin (3, 27).”
BackgroundResultThe Evaluation of Osteoporosis
Selby, J. B., & Gordon, L. L. (1994) · Clinical Nuclear Medicine · doi:10.1097/00003072-199407000-00025 · Cited by 90
Evaluation of Bone Mineral Metabolism in Children Receiving Carbamazepine and Valproic Acid
Altay, E. E., Serdaroğlu, A., Tümer, L., Gücüyener, K., & Hasanoğlu, A. (2000) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2000.13.7.933 · Cited by 89 · cited 1×
“In the two studies in children on valproate vs carbamazepine, patients on valproate had BMD close to or a little lower than expected, while patients on carbamazepine had BMD a little, but not significantly higher than expected (37, 38).”
BackgroundBone mineral metabolism changes in epileptic children receiving valproic acid
Öner, N., Kaya, M., KARASALİHOĞLU, S. T., Karaca, H., Çeltık, C., & Tütüncüler, F. (2004) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2004.00431.x · Cited by 86
Reducing the risk for distal forearm fracture: preserve bone mass, slow down, and don’t fall!
Kelsey, J. L., Prill, M. M., Keegan, T. H. M., Tanner, H. E., BERNSTEIN, A. L., Quesenberry, C. P., & Sidney, S. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1745-8 · Cited by 77
Risk of Age‐Related Fractures in Patients with Unprovoked Seizures
Annegers, J. F., III, L. J. M., Sun, C., & Hauser, W. A. (1989) · Epilepsia · doi:10.1111/j.1528-1157.1989.tb05308.x · Cited by 74 · cited 2×
“5) N/A N/A Cohort All residents (n 1⁄4 467) in a county with a seizure diagnosis (n 1⁄4 383 with epilepsy), patients compared with standard population rates 383 USA (62)”
BackgroundStrontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies
Reginster, J., & Meunier, P. J. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1349-0 · Cited by 61 · cited 1×
“The latter may be achieved through the use of (i) calcium plus vitamin D (50, 51) – this is of particular importance in institutionalized, and elderly subjects (25), or (ii) antiosteoporotic drugs [bisphosphonates (52–54), SERMs (55), strontium (56, 57), and in selected cases parathyroid hormone (58)].”
BackgroundAnticonvulsant Osteomalacia Determined by Quantitative Analysis of Bone Changes
Mosekilde, L., & Melsen, F. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb06747.x · Cited by 56 · cited 1×
“Osteomalacia is a condition where there is deficiency in calcium in the bone matrix, whereas the content of un-mineralized matrix is increased (19, 20).”
BackgroundKubota, F., Kifune, A., Shibata, N., Akata, T., Takeuchi, K., Takahashi, S., Ohsawa, M., & Takama, F. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00077-1 · Cited by 46
Mosekilde, L., & Melsen, F. (1980) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(80)90001-6 · Cited by 42 · cited 1×
“The decreased bone mineral in the skeleton may be the result of antiepileptic drugs (AEDs) having an influence on bone metabolism (10, 11).”
BackgroundFractional Intestinal Calcium Absorption in Epileptics on Anticonvulsant Therapy.
Mosekilde, L., Hansen, H. H., Christensen, M. S., Lund, B., Sørensen, O. H., Melsen, F., & Normany, A. W. (1979) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1979.tb06073.x · Cited by 28
IATROGENIC OSTEOMALACIA IN EPILEPTIC CHILDREN
Christiansen, C., Rødbro, P., & Nielsen, C. (1975) · Acta Paediatrica · doi:10.1111/j.1651-2227.1975.tb03825.x · Cited by 28
INITIAL AND MAINTENANCE DOSES OF VITAMIN D2 IN THE TREATMENT OF ANTICONVULSANT OSTEOMALACIA
Christiansen, C., & Rødbro, P. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1974.tb02808.x · Cited by 17
Cited by
Rapp, K., Büchele, G., Dreinhöfer, K., Bücking, B., Becker, C., & Benzinger, P. (2019) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-018-1382-z · Cited by 195
“Other diseases have beenalsofoundtobeassociatedwithfractures, such as depression or epilepsy [37, 38].”
BackgroundDepression and osteoporosis: epidemiology and potential mediating pathways
Mezuk, B., Eaton, W. W., & Golden, S. H. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0449-2 · Cited by 134
“Other medical conditions associated with both depression and BMD include epilepsy [73], Crohn’s disease [74], rheumatoid arthritis [75], and systemic lupus erythematosus [76].”
BackgroundCamfield, C., & Camfield, P. (2015) · Seizure · doi:10.1016/j.seizure.2015.02.031 · Cited by 58
“A meta-analysis of the fracture risk in epilepsy found that fractures were approximately twice as common as controls [18].”
Ketogenic Diet Compromises Both Cancellous and Cortical Bone Mass in Mice
Wu, X., Huang, Z., Wang, X., Fu, Z., Liu, J., Huang, Z., Kong, G., Xu, X., Ding, J., & Zhu, Q. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0292-1 · Cited by 41
Metadata
- Authors
- Vestergaard, P.
- Venue
- Acta Neurologica Scandinavica
- Publisher
- Hindawi Limited
- Published
- 2005-11
- Volume
- 112
- Issue
- 5
- Pages
- 277-286
- ISSN
- 0001-6314 (ISSN-L)
- 1600-0404
- OpenAlex
- W2154209841
- Cited by
- 223
- References
- 46
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.